StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Check out SEDI boys and girls

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Jan 26, 2023 10:05am

295 Views

Post# 35247563

RE:RE:Check out SEDI boys and girls

The company extends $6 million in warrants varrying in exercise price from $0.48 to $1.53. Now they grant options to directors at a price of 0.065.

It's almost like the company feels the share price will increase from here. Now why would that be?

Nailbiter2 wrote:

Filed 2023-01-25 23:44

Tx date 2023-01-24 $SZLS
StageZero Life Sciences Ltd. Riggs, Rory
4 - Director of Issuer

Direct Ownership

Options
50 - Grant of options $49,725
+765,000 vol
.065 each 1,569,117

Filed 2023-01-25 23:32

Tx date 2023-01-24 $SZLS
StageZero Life Sciences Ltd. MacRae, Garth A. C.
4 - Director of Issuer

Direct Ownership

Options
50 - Grant of options $49,725
+765,000 vol
.065 each 1,051,120

Filed 2023-01-25 23:29

Tx date 2023-01-24 $SZLS
StageZero Life Sciences Ltd. Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer

Direct Ownership

Options
50 - Grant of options $91,455
+1,407,000 vol
.065 each 3,818,250

Filed 2023-01-25 23:27

Tx date 2023-01-24 $SZLS
StageZero Life Sciences Ltd. Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer

Direct Ownership

Options
50 - Grant of options $49,725
+765,000 vol
.065 each 2,411,250

Filed 2023-01-25 23:22

Tx date 2023-01-24 $SZLS
StageZero Life Sciences Ltd. Glorikian, Harry
4 - Director of Issuer

Direct Ownership

Options
50 - Grant of options $49,725
+765,000 vol
.065 each 1,076,120

Older filings

Nailbiter2 wrote:

Filed 2023-01-25 23:44 Tx date 2023-01-24	$SZLS StageZero Life Sciences Ltd.	Riggs, Rory 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$49,725 +765,000 vol .065 each	1,569,117
Filed 2023-01-25 23:32 Tx date 2023-01-24	$SZLS StageZero Life Sciences Ltd.	MacRae, Garth A. C. 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$49,725 +765,000 vol .065 each	1,051,120
Filed 2023-01-25 23:29 Tx date 2023-01-24	$SZLS StageZero Life Sciences Ltd.	Howard-Tripp, James 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$91,455 +1,407,000 vol .065 each	3,818,250
Filed 2023-01-25 23:27 Tx date 2023-01-24	$SZLS StageZero Life Sciences Ltd.	Howard-Tripp, James 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$49,725 +765,000 vol .065 each	2,411,250
Filed 2023-01-25 23:22 Tx date 2023-01-24	$SZLS StageZero Life Sciences Ltd.	Glorikian, Harry 4 - Director of Issuer Direct Ownership	Options 50 - Grant of options	$49,725 +765,000 vol .065 each	1,076,120
Older filings